204 related articles for article (PubMed ID: 8160579)
1. The role of cardioversion therapy in patients with implanted cardioverter defibrillators.
Nathan AW
Am Heart J; 1994 Apr; 127(4 Pt 2):1046-51. PubMed ID: 8160579
[TBL] [Abstract][Full Text] [Related]
2. Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective.
Estes NA; Haugh CJ; Wang PJ; Manolis AS
Am Heart J; 1994 Apr; 127(4 Pt 2):1038-46. PubMed ID: 8160578
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.
Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Kelso D; Mitchell R
Circulation; 1993 Jun; 87(6):1889-96. PubMed ID: 8504501
[TBL] [Abstract][Full Text] [Related]
4. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
Ganjehei L; Nazeri A; Massumi A; Razavi M
Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
[TBL] [Abstract][Full Text] [Related]
5. Delayed termination of ventricular tachycardia after cardioversion.
Stiles MK; Lau DH; Young GD; Sanders P
Europace; 2007 Sep; 9(9):730-1. PubMed ID: 17639067
[TBL] [Abstract][Full Text] [Related]
6. Pacing induced ventricular fibrillation in internal cardioverter defibrillator patients: a new form of proarrhythmia.
Vlay LC; Vlay SC
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):132-3. PubMed ID: 9121960
[TBL] [Abstract][Full Text] [Related]
7. Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. Multicenter PCD Investigator Group.
Hammill SC; Packer DL; Stanton MS; Fetter J
Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 1):3-10. PubMed ID: 7700828
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs.
Rankin AC; Zaim S; Powell A; Zaim B; Brooks R; McGovern BA; Garan H; Ruskin JN
Br Heart J; 1993 Jul; 70(1):61-9. PubMed ID: 8038001
[TBL] [Abstract][Full Text] [Related]
9. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
[TBL] [Abstract][Full Text] [Related]
10. Innovations in pulse generators and lead systems: balancing complexity with clinical benefit and long-term results.
Saksena S; Krol RB; Kaushik RR
Am Heart J; 1994 Apr; 127(4 Pt 2):1010-21. PubMed ID: 8160574
[TBL] [Abstract][Full Text] [Related]
11. Is this pacemaker working properly? Prolongation of the atrial escape interval following activation of the ventricular safety pacing algorithm in a dual-chamber implantable cardioverter defibrillator with atrial-based, lower rate timing.
Johri AM; Baranchuk A; Simpson CS; Redfearn DP; Abdollah H
Can J Cardiol; 2008 Jul; 24(7):e43-4. PubMed ID: 18612507
[TBL] [Abstract][Full Text] [Related]
12. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
Francisco GM; Sharma S; Dougherty AH; Kantharia BK
Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
[TBL] [Abstract][Full Text] [Related]
13. Monitoring an unstable heart. Implantable cardioverter-defibrillators.
Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395
[No Abstract] [Full Text] [Related]
14. Application of new pacemaker and defibrillator technology.
Shepard RB; Epstein AE; Kay GN
Adv Card Surg; 1994; 5():181-208. PubMed ID: 8118592
[No Abstract] [Full Text] [Related]
15. Implantable cardioverter defibrillators: a guide for clinicians.
Davidson T; VanRiper S; Harper P; Wenk A
Heart Lung; 1994; 23(3):205-15; quiz 216-7. PubMed ID: 8039991
[TBL] [Abstract][Full Text] [Related]
16. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.
Arenal A; Proclemer A; Kloppe A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
Europace; 2016 Nov; 18(11):1719-1725. PubMed ID: 27485577
[TBL] [Abstract][Full Text] [Related]
17. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
[TBL] [Abstract][Full Text] [Related]
18. Antitachycardia pacing and implantable cardioverter defibrillators.
Furman S; Mercando AD
Annu Rev Med; 1989; 40():123-36. PubMed ID: 2729924
[TBL] [Abstract][Full Text] [Related]
19. Impact of device programming on the success of the first anti-tachycardia pacing therapy: An anonymized large-scale study.
Shakibfar S; Krause O; Lund-Andersen C; Strycko F; Moll J; Osman Andersen T; Høgh Petersen H; Hastrup Svendsen J; Igel C
PLoS One; 2019; 14(8):e0219533. PubMed ID: 31393871
[TBL] [Abstract][Full Text] [Related]
20. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
